Related Experiment Video
Updated: May 3, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Coronary surgery in patients with low ejection fraction: mid-term results
Kazim Ergünes1, Ismail Yurekli, Banu Lafci
1Department of Cardiovascular Surgery, İzmir Atatürk Training and Research Hospital, Izmir, Turkey.
Background:
The aim of this study was to investigate the effect of preoperative low ejection fraction (≤30%) on postoperative morbidity and mortality in patients undergoing isolated on-pump coronary artery bypass grafting. We also investigated the effect of pre- and perioperative factors on survival.
Methods:
Between January 2002 and December 2009, 103 (6.2%) patients with an ejection fraction ≤30% and 1554 (93.8%) with an ejection fraction >30% underwent coronary artery bypass grafting.
Results:
In multivariate logistic regression analysis, cardiopulmonary bypass time, operation time, prolonged inotropic support, and intensive care unit stay were independent predictors of mortality in patients with low ejection fraction. Intensive care unit and hospital stays were significantly longer in these patients, and the postoperative mortality rate was significantly higher. Advanced age (≥70 years) influenced mortality during the follow-up of patients with low ejection fraction. Midterm survival was significantly reduced in patients with ejection fraction ≤30%. Smoking, prolonged inotropic support, and prolonged ventilatory support were independent predictors of midterm survival in patients with ejection fraction ≤30%.
Conclusion:
On-pump coronary artery bypass grafting can be performed in patients with ejection fraction ≤30%, with reasonable mortality and morbidity rates.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Coronary Artery Disease V: Interprofessional Care
Mitral Stenosis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations

